☰

James Bradner, MD

Affiliations: 
Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States 
Google:
"James Bradner"
Mean distance: 39813
 
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Stuart L. Schreiber post-doc Harvard

Children

Sign in to add trainee
Emma J Chory research assistant
Christopher Ott post-doc MGH
Jun Qi research scientist Dana-Farber Cancer Institute, Harvard Medical School

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Souroullas GP, Jeck WR, Parker JS, et al. (2024) Author Correction: An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation. Nature Medicine
Hudson L, Mason JW, Westphal MV, et al. (2023) Author Correction: Diversity-oriented synthesis encoded by deoxyoligonucleotides. Nature Communications. 14: 7589
Hudson L, Mason JW, Westphal MV, et al. (2023) Diversity-oriented synthesis encoded by deoxyoligonucleotides. Nature Communications. 14: 4930
de Matos Simoes R, Shirasaki R, Downey-Kopyscinski SL, et al. (2023) Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias. Nature Cancer. 4: 754-773
Chory EJ, Wang M, Ceribelli M, et al. (2023) High-throughput Approaches to Uncover Synergistic Drug Combinations in Leukemia. Slas Discovery : Advancing Life Sciences R & D
Hess L, Moos V, Lauber AA, et al. (2022) A toolbox for class I HDACs reveals isoform specific roles in gene regulation and protein acetylation. Plos Genetics. 18: e1010376
Zaiken MC, Flynn R, Paz KG, et al. (2022) BET-bromodomain and EZH2 inhibitor treated chronic GVHD mice have blunted germinal centers with distinct transcriptomes. Blood
Liao Y, Chen CH, Xiao T, et al. (2022) Inhibition of EZH2 transactivation function sensitizes solid tumors to genotoxic stress. Proceedings of the National Academy of Sciences of the United States of America. 119
Gill T, Wang H, Bandaru R, et al. (2021) Selective targeting of MYC mRNA by stabilized antisense oligonucleotides. Oncogene
Hideshima T, Mazitschek R, Qi J, et al. (2021) Correction: HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancer. Oncotarget. 12: 1736
See more...